Paul E. Sax - Concepedia

Author

Paul E. Sax

Also Known As

Carlos del Rio, D. Salmon Ceron, Gandhi, Monica, Haubrich, Richard, Helmut Albrecht, Hicks, Charles, Hindman, Jason T, Hoy, Jennifer F., J P Breux, Matthew Planchon

717

Publications

22.4K

Citations

H-Index

121

Concepts

All Affiliations

Brigham and Women's Hospital Harvard University Massachusetts General Hospital Gilead Sciences (United States)University of North Carolina at Chapel Hill

About

Paul E. Sax is an author at Brigham and Women's Hospital specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	42	4.8K
2	Public Health	14	15	797
3	Social Sciences	2	2	51
4	Health Sciences	1	1	678
5	Cardiothoracic Surgery	1	1	15

Paul E. Sax

149

Publications

18.9K

Citations

H-Index

Page 1

	Year	Citations
Vigorous HIV-1-Specific CD4 <sup>+</sup> T Cell Responses Associated with Control of Viremia Eric Rosenberg, James M. Billingsley, Angela M. Caliendo, Science	1997	1.8K
Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials Paul E. Sax, Kristine M. Erlandson, Jordan E. Lake, Clinical Infectious Diseases	2019	723
Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy Colleen Hadigan, James B. Meigs, Colleen Corcoran, Clinical Infectious Diseases ObesityMetabolic SyndromeBody CompositionMetabolic DisorderCardiovascular Disease	2001	678
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults Huldrych F. Günthard, Michael S. Saag, Constance A. Benson, JAMA	2016	646
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials Paul E. Sax, David A. Wohl, Michael T. Yin, The Lancet Treatment And PreventionMedicineAntiviral Drug DevelopmentClinical TrialsAntiviral Therapy	2015	593
The Survival Benefits of AIDS Treatment in the United States Rochelle P. Walensky, A. David Paltiel, Elena Losina, The Journal of Infectious Diseases	2006	581
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults Michael S. Saag, Constance A. Benson, Rajesh T. Gandhi, JAMA	2018	551
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults Rajesh T. Gandhi, Roger Bedimo, Jennifer Hoy, JAMA	2022	523
Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202 Grace A. McComsey, Douglas Kitch, Eric S. Daar, The Journal of Infectious Diseases	2011	495
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1 Susanna Naggie, Curtis Cooper, Michael S. Saag, New England Journal of Medicine	2015	463

Page 1